|
 |
EXERCISE
The page is no longer available. You may want to read the following pages.
S Haas, T Vos, R Gilbert... - 52nd Annual Scientific ..., 2011 - , S., Vos, T., Gilbert, R. and Krum, H. (2003). Does the magnitude of the beneficial effect
of beta-blockers in chronic heart failure differ between diabetic and nondiabetic patients? A
meta-analysis of all-cause mortality outcomes from major chronic heart failure ...
PE Fournier, R Charrel... - Clinical Infectious ..., 2011 - cid.oxfordjournals.org1. Correspondence: Didier Raoult, MD, Unite de Recherche sur les Maladies Infectieuses Tropicales et Emergentes, UMR CNRS 6236IRD 198, Facult de Medecin, Universit de la Mditerrane, 27 Blvd Jean Moulin, 13385 Marseille Cedex 5, France (didier. raoult {at} ...
A Meinitzer, JT Kielstein, S Pilz... - Clinical ..., 2011 - Am Assoc Clin Chem BACKGROUND: Asymmetrical dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor, has been linked to cardiovascular risk. The clinical role of its structural isomer symmetrical dimethylarginine (SDMA) remains largely unclear. METHODS: We ...
D Kromhout, JM Geleijnse, J de Goede... - Diabetes ..., 2011 - Am Diabetes Assoc OBJECTIVE We carried out a secondary analysis in high-risk patients with a previous myocardial infarction (MI) and diabetes in the Alpha Omega Trial. We tested the hypothesis that in these patients an increased intake of the n-3 fatty acids eicosapentaenoic acid ( ...
G Thanassoulis, GM Peloso, MJ Pencina... - Circulation: ..., 2012 - Am Heart Assoc... The addition of recently discovered SNPs did not significantly improve the performance
of this GRS. Key words: Genetics, single nucleotide polymorphisms, cardiovascular
disease, coronary heart disease, risk prediction, reclassification ...
|
|
|
